China (Mainland)
Premiumsupplier
BDTX-1535 CAS NO.2607829-38-7
- Min.Order: 100 Gram
- Payment Terms: L/C,T/T
- Available Specifications:
- Product Details
Keywords
- (2E)-N-[4-[(3-Chloro-2-fluorophenyl)amino]-7-[2-[(1R,5S)-3-methyl-3-azabicyclo[3.1.0]hex-1-yl]ethynyl]-6-quinazolinyl]-4-(4-morpholinyl)-2-butenamide
- EGFR-IN-76
- 2-Butenamide
Quick Details
- ProName: BDTX-1535
- CasNo: 2607829-38-7
- Molecular Formula: C30H30ClFN6O2
- Appearance: Yellow solid
- Application: BDTX-1535 (EGFRIN-76) is a fourth-gene...
- DeliveryTime: 2 months
- PackAge: fiber can
- Port: shanghai port
- ProductionCapacity: 100 Kilogram/Year
- Purity: 99%
- Storage: store at 2-8℃
- Transportation: air transport
- LimitNum: 100 Gram
- Related Substances: ≤0.1%
- Residue on Ignition: ≤0.1%
- Heavy Metal: ≤20ppm
- Valid Period: 2 years
Superiority
The quality of our products is guaranteed and the price is low！
Details
English named:BDTX1535
2-Butenamide,N-[4-[(3-chloro-2-fluorophenyl)amino]-7-[2-[(1R,5S) -3-methyl-3-Azabicyclo [3.1.0]hex-1-yl]ethynyl]-6-qui nazolinyl]-4-(4-morpholinyl)-,(2E)-
English synonyms :2-butenamide,N-[4-[(3Chemicalbook-chloro-2-fluorophenyl)amino]-7-[2-[(1R,5S) -3-methyl-3-Azabicyclo [3.1.0]hex-1-yl]e thynyl]-6-quinazolinyl]-4-(4-morpholinyl)-,(2E)-; BDTX-1535
CAS number 2607829-38-7
Molecular formula C30H30ClFN6O2
Molecular weight 561.05
Boiling point 730.0±60.0 °C(Predicted)
Density 1.42± 0.1g /cm3(Predicted)
Acidity coefficient (pKa)11.44±0.43(Predicted)
Form solid: color light yellow to yellow
Storage 0-4℃, can be stored for a few days to a few weeks; -20℃, can be stored for several months.
Soluble in DMSO and other organic solvents
Processing refers to MSDS
Transport conditions can be transported at room temperature.
Customs Code: 2934200090
BDTX-1535 (EGFRIN-76) is a fourth-generation, blood-brain barrier penetrating tyrosine kinase inhibitor (TKI). BDTX-1535 targets a wide range of oncogenic EGFR mutations in non-small cell lung cancer (NSCLC), including classical and non-classical drive mutations and C797S mutations. In addition, BDTX-1535 also inhibits EGFR extracellular domain mutations common in glioblastoma (GBM).